Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary.
Business Model:
Revenue: $10M
Employees: 11-50
Address: 295 Madison Avenue
City: New York
State: NY
Zip: 10017
Country: US
Eyenovia is a New York-based ophthalmic company that develops and commercializes novel therapeutics for the treatment of eye diseases.
Contact Phone:
+18137669539
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2022 | Post-IPO Equity | $15M |
Armistice Capital Master Fund Ltd |
3/2020 | Private Placement | $6M | 1/2018 | IPO | $27.3M | 5/2021 | Post-IPO Debt | $25M |
Silicon Valley Bank |
11/2022 | Post-IPO Debt | $15M |
Avenue Venture Opportunities Fund, L.P. Avenue Venture Opportunities Fund, L.P. |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|